openPR Logo
Press release

Gabapentin Market CAGR to be at 4.37% | $3,036.38 Million Industry Revenue By 2032

07-05-2024 07:37 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Gabapentin Market

Gabapentin Market

๐†๐š๐›๐š๐ฉ๐ž๐ง๐ญ๐ข๐ง-๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐’๐ข๐ณ๐ž ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ, ๐š๐ง๐ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ ๐š๐›๐š๐ฉ๐ž๐ง๐ญ๐ข๐ง ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ž๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž๐ ๐ญ๐จ ๐›๐ž ๐ฐ๐จ๐ซ๐ญ๐ก ๐”๐’๐ƒ ๐Ÿ,๐Ÿ—๐Ÿ–๐Ÿ.๐Ÿ”๐ŸŽ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ ๐š๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐ž๐๐ข๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ž๐ฑ๐ฉ๐š๐ง๐ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ‘,๐ŸŽ๐Ÿ‘๐Ÿ”.๐Ÿ‘๐Ÿ– ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ฐ๐ข๐ญ๐ก ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ’.๐Ÿ‘๐Ÿ•% ๐๐ฎ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐œ๐จ๐ฉ๐ž:

This comprehensive study provides an accurate overview of the worldwide gabapentin industry. It includes comprehensive analyses of sales volume, price, revenue, market share, and important companies. The market is further divided into segments by dosage, type, application, distribution channel, and region, offering a comprehensive picture of the gabapentin market state.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐ญ๐จ ๐†๐š๐ข๐ง ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ : https://www.polarismarketresearch.com/industry-analysis/gabapentin-market/request-for-sample

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐Ÿ๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:

Among other names, gabapentin is a brand-named anticonvulsant drug that is mostly prescribed to treat neuropathic pain and partial seizures. It is a drug that is frequently used to treat central pain, postherpetic neuralgia, and neuropathic pain brought on by diabetic neuropathy. The most frequent adverse effects are tiredness and lightheadedness. An increased risk of suicide, respiratory depression, and allergic reactions are examples of serious adverse effects. For people with renal illness, lower doses are advised. A subgroup of calcium channels had their activity reduced by gabapentin.

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐“๐ซ๐ž๐ง๐๐ฌ:

โ— As the population ages, chronic pain and neurological illnesses are predicted to become more common, increasing demand for drugs such as gabapentin.

โ— The rise of e-commerce has made it easier for people to buy pharmaceuticals like gabapentin online, boosting access to the drug for patients who may not have easy access to a traditional pharmacy.

๐“๐จ๐ฉ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ:

Because there are so many companies in the industry, it is expected to be both competitive and fragmented. Here are the top companies in the gabapentin market:
โ€ข Pfizer Inc.
โ€ข Teva Pharmaceutical Industries Ltd.
โ€ข Sun Pharmaceutical Industries Ltd. Aurobindo Pharma Ltd.
โ€ข Lupin Limited
โ€ข Mylan N.V.
โ€ข Cipla Limited
โ€ข Hikma Pharmaceuticals PLC
โ€ข Arbor Pharmaceuticals Inc.
โ€ข Zydus Cadila Healthcare Limited
โ€ข Glenmark Pharmaceuticals Ltd.
โ€ข Apotex Inc.
โ€ข Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd.
โ€ข Wockhardt Ltd

๐‚๐ฅ๐ข๐œ๐ค ๐จ๐ง ๐ญ๐ก๐ž ๐๐ž๐ฅ๐จ๐ฐ ๐‹๐ข๐ง๐ค ๐ญ๐จ ๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ : https://www.polarismarketresearch.com/buy/2178/2

๐‚๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐–๐ข๐ฌ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

According to regional research, the demand in North America is expected to witness significant growth during the forecast period. The demand for Gabapentin is expected to increase in various regions due to its efficacy and safety profile. Also, the Asia-Pacific region is expected to witness significant growth in the demand for gabapentin due to the increasing prevalence of neurological disorders, such as epilepsy and neuropathic pain. The rising healthcare spending and increasing awareness about the benefits of gabapentin are expected to drive the demand for the medication in the region.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:

๐˜ฝ๐™ฎ ๐˜ฟ๐™ค๐™จ๐™–๐™œ๐™š :

โ€ข Capsule
โ€ข Tablet

๐˜ฝ๐™ฎ ๐™๐™ฎ๐™ฅ๐™š :

โ€ข Branded
โ€ข Generic

๐˜ฝ๐™ฎ ๐˜ผ๐™ฅ๐™ฅ๐™ก๐™ž๐™˜๐™–๐™ฉ๐™ž๐™ค๐™ฃ :

โ€ข Neuropathic Pain
โ€ข Epilepsy
โ€ข Restless Legs Syndrome
โ€ข Others

๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐“๐Ž๐‚ ๐ฐ๐ข๐ญ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐ž๐ฏ๐ข๐ž๐ฐ: https://www.polarismarketresearch.com/industry-analysis/gabapentin-market

๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐“๐Ž๐‚ ๐ฐ๐ข๐ญ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐ž๐ฏ๐ข๐ž๐ฐ:

๐™Š๐™ฅ๐™๐™ฉ๐™๐™–๐™ก๐™ข๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/ophthalmic-drug-market
๐™ˆ๐™ฎ๐™–๐™จ๐™ฉ๐™๐™š๐™ฃ๐™ž๐™– ๐™‚๐™ง๐™–๐™ซ๐™ž๐™จ ๐˜ฟ๐™ž๐™จ๐™š๐™–๐™จ๐™š ๐™๐™ง๐™š๐™–๐™ฉ๐™ข๐™š๐™ฃ๐™ฉ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/myasthenia-gravis-disease-treatment-market
๐™‰๐™š๐™ช๐™ง๐™ค๐™ก๐™ค๐™œ๐™ž๐™˜๐™–๐™ก ๐˜ฝ๐™ž๐™ค๐™ข๐™–๐™ง๐™ ๐™š๐™ง๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market
๐™„๐™ค๐™ ๐™ˆ๐™š๐™™๐™ž๐™˜๐™–๐™ก ๐˜ฟ๐™š๐™ซ๐™ž๐™˜๐™š๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/iot-medical-devices-market
๐˜พ๐™š๐™ก๐™ก ๐˜ฟ๐™ž๐™จ๐™จ๐™ค๐™˜๐™ž๐™–๐™ฉ๐™ž๐™ค๐™ฃ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/cell-dissociation-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gabapentin Market CAGR to be at 4.37% | $3,036.38 Million Industry Revenue By 2032 here

News-ID: 3567124 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Mobile Biometrics Market is projected to reach USD 271.62 Billion by 2034, expanding at a strong CAGR of 19.88% during the forecast period from 2026 to 2034.
Mobile Biometrics Market is projected to reach USD 271.62 Billion by 2034, expan โ€ฆ
The global mobile biometrics market is projected to be valued at approximately USD 53.10 billion in 2025 and is expected to witness strong growth through 2034, driven by rising concerns over data security, increasing smartphone-based digital transactions, and the growing adoption of biometric authentication across banking, enterprise, and government sectors. The market is anticipated to expand at a CAGR of 19.88% during the forecast period, reaching an estimated value ofโ€ฆ
Global Bioregenerative Aesthetic Injectables Market Set for Strong Growth During 2026-2034 | AbbVie Inc., Croma-Pharma GmbH, Hugel, Inc.
Global Bioregenerative Aesthetic Injectables Market Set for Strong Growth During โ€ฆ
Polaris Market Research recently introduced the latest update on Bioregenerative Aesthetic Injectables Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous analysis of the Bioregenerative Aesthetic Injectables Market size, share, demand, key growth factors, segmentation, country-level overview, and forecast. The report helps businesses get a thorough understanding of theโ€ฆ
Copper Mining Market Projected to Reach USD 235.28 Billion by 2034, Growing at a 2.29% CAGR from 2026 to 2034
Copper Mining Market Projected to Reach USD 235.28 Billion by 2034, Growing at a โ€ฆ
Global Copper Mining Market is currently valued at USD 191.96 Billion in 2025 and is anticipated to generate an estimated revenue of USD 235.28 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 2.29% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034 Polaris Market Research has introduced the latest market research report titled Copperโ€ฆ
Specialty Oilfield Chemicals Market Projected to Reach USD 16.7 Billion by 2034, Expanding at a 4.9% CAGR from 2026 to 2034
Specialty Oilfield Chemicals Market Projected to Reach USD 16.7 Billion by 2034, โ€ฆ
Global Specialty Oilfield Chemicals Market is currently valued at USD 11.0 Billion in 2025 and is anticipated to generate an estimated revenue of USD 16.7 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.9% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2026 - 2034 Polaris Market Research has introduced the latest market research report titledโ€ฆ

All 5 Releases


More Releases for Pharma

Schizophrenia Market Gains Momentum with Expanding Pipeline and Investment Poten โ€ฆ
The Key Schizophrenia Companies in the market include - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Acadia Pharmaceuticals, Boehringer Ingelheim, Cerevel Therapeutics, AstraZeneca, Eli Lilly and Company, Karuna Therapeutics, Neurocrine Biosciences, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2036" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailedโ€ฆ
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva โ€ฆ
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand theโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโ€ฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โ€ฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโ€ฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โ€ฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoringโ€ฆ